SpectraBase Spectrum ID |
DmqCZkgKLdw |
Name |
Pentobarbitone-M (OH) |
Classification |
Pharmaceutical drug metabolite |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.13 (c) (3) |
DEA Controlled Substance Form |
Any compound, mixture or preparation |
DEA Controlled Substance Name |
Barbituric acid derivatives |
DEA Controlled Substance Type |
Salts, isomers, derivatives and salts of isomers and derivatives |
DEA Controlled Substances Code Number |
2100 |
DEA Schedule |
Schedule III |
DEA Section |
Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system |
Exact Mass |
242.126657064 u |
Formula |
C11H18N2O4 |
InChI |
InChI=1S/C11H18N2O4/c1-4-11(6(2)5-7(3)14)8(15)12-10(17)13-9(11)16/h6-7,14H,4-5H2,1-3H3,(H2,12,13,15,16,17) |
InChIKey |
XYOPMDJVSWQZTM-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
242.275 g/mol |
Nominal Mass |
242 u |
Quality |
728 |
Retention Index |
1932 |
SMILES |
OC(CC(C1(C(NC(NC1=O)=O)=O)CC)C)C |
SPLASH |
splash10-0a4i-1900000000-26967384bcafbc6992cc |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
5-ethyl-5-(4-hydroxypentan-2-yl)-1,3-diazinane-2,4,6-trione |
Technique |
GC/MS |
Wiley ID |
DD2024_003509 |